Trilogy Capital’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-11,394
| Closed | -$328K | – | 316 |
|
|
2024
Q1 | $328K | Sell |
11,394
-1,119
| -9% | -$32.2K | 0.02% | 245 |
|
|
2023
Q4 | $411K | Buy |
+12,513
| New | +$411K | 0.03% | 187 |
|
|
2023
Q3 | – | Sell |
-9,422
| Closed | -$350K | – | 259 |
|
|
2023
Q2 | $350K | Buy |
+9,422
| New | +$350K | 0.02% | 202 |
|
|
2023
Q1 | – | Sell |
-10,268
| Closed | -$290K | – | 243 |
|
|
2022
Q4 | $290K | Buy |
+10,268
| New | +$290K | 0.02% | 208 |
|